Gina Chapman's most recent trade in Entrada Therapeutics Inc was a trade of 19,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entrada Therapeutics Inc | Gina Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Gina Chapman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 200,000 | 303,905 | - | 0 | Common Stock | |
| CARGO Therapeutics Inc | Gina Chapman | Director, President & CEO | 18 Sep 2024 | 7,166 | 111,071 | - | 5.0 | 36,045 | Common Stock | |
| CARGO Therapeutics Inc | Gina Chapman | Director, President & CEO | 18 Sep 2024 | 7,166 | 552,490 | - | - | Stock Option (Right to Buy) | ||
| CARGO Therapeutics Inc | Gina Chapman | Director, President & CEO | 18 Sep 2024 | 7,166 | 103,905 | - | 25.1 | 179,775 | Common Stock | |
| CARGO Therapeutics Inc | Gina Chapman | Director, President & CEO | 18 Sep 2024 | 2,975 | 549,515 | - | - | Stock Option (Right to Buy) | ||
| CARGO Therapeutics Inc | Gina Chapman | Director, President & CEO | 18 Sep 2024 | 2,975 | 103,905 | - | 25.0 | 74,457 | Common Stock | |
| CARGO Therapeutics Inc | Gina Chapman | Director, President & CEO | 18 Sep 2024 | 2,975 | 106,880 | - | 5.0 | 14,964 | Common Stock | |
| Entrada Therapeutics Inc | Gina Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Gina Chapman | Director, President & CEO | 01 Mar 2024 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) |